Trial intelligence / Profile preview

Jefferson 2-Step Approach for Haploidentical HSCT

NCT00429143Phase 2Completed

Sponsor
Sidney Kimmel Comprehensive Cancer Center
Start
Jan 2006
Primary completion
Aug 2009
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of donor lymphocyte infusion in hematologic malignancy, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jan 2006; status: completed.

02

Drugs

donor lymphocyte infusion
03

Conditions

hematologic malignancy

Beyond the preview

Go deeper on NCT00429143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00429143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call